We are live on
!
Find out more
HC
Highmount Capital Portfolio holdings
AUM
$391M
Turnover
10.22%
1-Year Est. Return
2.65%
This Fund
S&P 500
This Quarter
Est. Return
+7.41%
1 Year Est. Return
+2.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$435M
AUM Growth
+$29.9M
(+7.4%)
Cap. Flow
+$4.18M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
46.97%
Holding
148
New
18
Increased
60
Reduced
30
Closed
4
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$3.16M |
| 2 |
Agilent Technologies
A
|
+$3.06M |
| 3 |
Citigroup
C
|
+$3.02M |
| 4 |
Travel + Leisure Co
TNL
|
+$2.79M |
| 5 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$2.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.2M |
| 2 |
Tortoise Energy Infrastructure Corp
TYG
|
+$3.12M |
| 3 |
Coca-Cola
KO
|
+$2.69M |
| 4 |
Procter & Gamble
PG
|
+$2.67M |
| 5 |
Cognizant
CTSH
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.19% |
| 2 | Financials | 10.58% |
| 3 | Technology | 7.75% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Berkshire Hathaway Class B
BRK.B
$1.13T
| $279K | 0.06% |
2,355
-75
| -3% | -$8.67K |
2013 Q2
2 quarters
|
|
127
DELISTED
Stericycle Inc
SRCL
| $278K | 0.06% |
2,395
| – | – |
2013 Q3
1 quarter
|
|
128
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
| $276K | 0.06% |
8,000
| – | – |
2013 Q2
2 quarters
|
|
129
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.4B
| $274K | 0.06% |
2,400
+1,000
| +71% | +$114K |
2013 Q2
2 quarters
|
|
130
Cisco
CSCO
$433B
| $273K | 0.06% |
12,168
+1,000
| +9% | +$22.1K |
2013 Q2
2 quarters
|
|
131
Healthcare Services Group
HCSG
$1.47B
| $270K | 0.06% |
9,515
| – | – |
2013 Q3
1 quarter
|
|
|
WFM
132
DELISTED
Whole Foods Market Inc
WFM
| $243K | 0.06% |
4,196
-1,230
| -23% | -$72.9K |
2013 Q3
1 quarter
|
|
133
Charles Schwab
SCHW
$163B
| $229K | 0.05% |
+8,800
| New | +$210K |
2013 Q4
0 quarters
|
|
|
AGN
134
DELISTED
Allergan Inc
AGN
| $225K | 0.05% |
+2,030
| New | +$194K |
2013 Q4
0 quarters
|
|
135
Perrigo
PRGO
$2.29B
| $224K | 0.05% |
+1,460
| New | +$210K |
2013 Q4
0 quarters
|
|
136
L3Harris
LHX
$44.8B
| $213K | 0.05% |
+3,050
| New | +$193K |
2013 Q4
0 quarters
|
|
137
TJX Companies
TJX
$159B
| $212K | 0.05% |
+6,650
| New | +$202K |
2013 Q4
0 quarters
|
|
138
Parker-Hannifin
PH
$121B
| $207K | 0.05% |
+1,613
| New | +$187K |
2013 Q4
0 quarters
|
|
139
Polaris
PII
$3.04B
| $204K | 0.05% |
+1,400
| New | +$187K |
2013 Q4
0 quarters
|
|
140
Union Pacific
UNP
$172B
| $204K | 0.05% |
+2,432
| New | +$193K |
2013 Q4
0 quarters
|
|
141
Walt Disney
DIS
$191B
| $203K | 0.05% |
+2,658
| New | +$184K |
2013 Q4
0 quarters
|
|
142
Costco
COST
$433B
| $202K | 0.05% |
+1,697
| New | +$203K |
2013 Q4
0 quarters
|
|
|
BFF
143
DELISTED
BFC FIN'L CP CL A
BFF
| $134K | 0.03% |
46,369
| – | – |
2013 Q2
2 quarters
|
|
|
144
Cognizant
CTSH
$29.6B
| – | – |
-49,440
| Closed | -$2.03M | – |
|
145
Mondelez International
MDLZ
$80.4B
| – | – |
-6,717
| Closed | -$211K | – |
|
146
Newmont
NEM
$122B
| – | – |
-7,440
| Closed | -$209K | – |
|
147
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| – | – |
0
| – | -$15K |
2013 Q2
2 quarters
|
|
|
BCR
148
DELISTED
CR Bard Inc.
BCR
| – | – |
-1,745
| Closed | -$201K | – |
|
Similar funds
GMCM
STI
RRC
CG
SCVF
F
R
SBK
Highmount Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Highmount Capital held 148 positions worth $435M, up 7.4% from $405M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Highmount Capital's Q4 2013 filing shows 18 new, 60 increased, 30 reduced and 4 closed positions. Its largest new stake was Agilent Technologies: 80,532 shares worth $3.29M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $10.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 59% a quarter earlier, followed by Financials and Technology.
- Highmount Capital's largest Q4 2013 buy was Agilent Technologies: 80,532 shares worth $3.29M.
- Highmount Capital added most to Vanguard Short-Term Corporate Bond ETF in Q4 2013, an estimated $3.16M increase.
- Highmount Capital's biggest Q4 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $10.2M.
- Highmount Capital fully exited Cognizant in Q4 2013, selling an estimated $2.03M.
- Highmount Capital's ten largest holdings make up 47% of its $435M portfolio in Q4 2013.
- Highmount Capital opened 18 new positions and closed 4 in Q4 2013.
- Highmount Capital's portfolio value rose 7.4% quarter-over-quarter to $435M.
Based on Highmount Capital's 13F filing for Q4 2013, filed 7 Feb 2014.